These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38189162)

  • 1. Successful multidisciplinary team management of placenta accreta spectrum disorder: A referral center model in a middle-income country.
    Muadtongon K; Rattanaburi A; Ajimakul T; Suphasynth Y; Jiamset I; Nantamongkolkul K; Suntharasaj T; Suwanrath C; Pruksanusak N; Petpichetchian C; Suksai M; Chainarong N; Sawaddisan R; Pranpanus S
    Int J Gynaecol Obstet; 2024 May; 165(2):813-822. PubMed ID: 38189162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placenta Accreta Spectrum Disorders - The Impact of the Creation of a Multidisciplinary Team on Maternal Outcomes in Portugal.
    Teixeira B; Pinto PV; Realista R; Silva M; Costa A; Machado AP; Moucho M
    Rev Bras Ginecol Obstet; 2023 Dec; 45(12):e747-e753. PubMed ID: 38141594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multidisciplinary management of placenta accreta spectrum (PAS) within a single tertiary centre: A ten-year experience.
    Yasin N; Slade L; Atkinson E; Kennedy-Andrews S; Scroggs S; Grivell R
    Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):550-554. PubMed ID: 30565213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
    Erfani H; Fox KA; Clark SL; Rac M; Rocky Hui SK; Rezaei A; Aalipour S; Shamshirsaz AA; Nassr AA; Salmanian B; Stewart KA; Kravitz ES; Eppes C; Coburn M; Espinoza J; Teruya J; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2019 Oct; 221(4):337.e1-337.e5. PubMed ID: 31173748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional multidisciplinary team approach to the management of placenta accreta spectrum disorder.
    Yao R; Nguyen HY; Hong L; Karagoyzyan D; Burruss S; Brar H; Staton M; Martin C; Balli K; Ioffe Y
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2190840. PubMed ID: 36927241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time.
    Shamshirsaz AA; Fox KA; Erfani H; Clark SL; Salmanian B; Baker BW; Coburn M; Shamshirsaz AA; Bateni ZH; Espinoza J; Nassr AA; Popek EJ; Hui SK; Teruya J; Tung CS; Jones JA; Rac M; Dildy GA; Belfort MA
    Am J Obstet Gynecol; 2017 Jun; 216(6):612.e1-612.e5. PubMed ID: 28213059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta.
    Marcellin L; Delorme P; Bonnet MP; Grange G; Kayem G; Tsatsaris V; Goffinet F
    Am J Obstet Gynecol; 2018 Aug; 219(2):193.e1-193.e9. PubMed ID: 29733839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol.
    Melber DJ; Berman ZT; Jacobs MB; Picel AC; Conturie CL; Zhang-Rutledge K; Binder PS; Eskander RN; Roberts AC; McHale MT; Ramos GA; Ballas J; Kelly TF
    Am J Obstet Gynecol; 2021 Oct; 225(4):442.e1-442.e10. PubMed ID: 34245679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal and fetal outcomes in placenta accreta after institution of team-managed care.
    Al-Khan A; Gupta V; Illsley NP; Mannion C; Koenig C; Bogomol A; Alvarez M; Zamudio S
    Reprod Sci; 2014 Jun; 21(6):761-71. PubMed ID: 24336676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 5-year experience on perinatal outcome of placenta accreta spectrum disorder managed by cesarean hysterectomy in southern Iranian women.
    Kasraeian M; Hashemi A; Hessami K; Alamdarloo SM; Vahdani R; Vafaei H; Najib FS; Shiravani Z; Razavi B; Homayoon N; Nayebi M; Bazrafshan K; Jahromi MA
    BMC Womens Health; 2021 Jun; 21(1):243. PubMed ID: 34130685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum.
    Zuckerwise LC; Craig AM; Newton JM; Zhao S; Bennett KA; Crispens MA
    Am J Obstet Gynecol; 2020 Feb; 222(2):179.e1-179.e9. PubMed ID: 31469990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placenta accreta spectrum: We can do better.
    Silveira C; Kirby A; Melov SJ; Nayyar R
    Aust N Z J Obstet Gynaecol; 2022 Jun; 62(3):376-382. PubMed ID: 34984671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of pregnancies complicated by placenta accreta spectrum utilizing a multidisciplinary care team in a rural state.
    Sandlin AT; Magann EF; Whittington JR; Schneider AM; Ramseyer AM; Hughes DS; Ounpraseuth ST
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5964-5969. PubMed ID: 33769169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
    Matsuzaki S; Mandelbaum RS; Sangara RN; McCarthy LE; Vestal NL; Klar M; Matsushima K; Amaya R; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol; 2021 Nov; 225(5):534.e1-534.e38. PubMed ID: 33894149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of placenta previa attached to cesarean scar for adverse pregnant outcomes in patients with placenta accreta spectrum disorders].
    Zheng WR; Yang XR; Sun J; Mu Y; Yan J; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Dec; 56(12):861-867. PubMed ID: 34954965
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcomes associated with peripartum hysterectomy in the setting of placenta accreta spectrum disorder.
    Overton E; Wen T; Friedman AM; Azad H; Nhan-Chang CL; Booker WA; Khoury-Collado F; Mourad M
    Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101174. PubMed ID: 37802412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation and Outcomes of a Model of Care for Placenta Accreta Spectrum in a Community-Based Private Practice.
    Wagner W; Loichinger M; Sidebottom AC; Wunderlich WL; Vacquier M; Jentink T; Aguilera MN; Ahanya SN; Morgan E; Parker M; Wothe DD
    Am J Perinatol; 2024 Jun; 41(8):1008-1018. PubMed ID: 35815573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open versus endovascular REBOA control of blood loss during cesarean delivery in the placenta accreta spectrum: A single-center retrospective case control study.
    Riazanova OV; Reva VA; Fox KA; Romanova LA; Kulemin ES; Riazanov AD; Ioscovich A
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():23-28. PubMed ID: 33388487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulopathy in surgical management of placenta accreta spectrum.
    Shamshirsaz AA; Fox KA; Erfani H; Clark SL; Hui SK; Shamshirsaz AA; Rezaei A; Nassr AA; Lake YN; Teruya J; Belfort MA
    Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():126-130. PubMed ID: 31029971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach.
    Shamshirsaz AA; Fox KA; Salmanian B; Diaz-Arrastia CR; Lee W; Baker BW; Ballas J; Chen Q; Van Veen TR; Javadian P; Sangi-Haghpeykar H; Zacharias N; Welty S; Cassady CI; Moaddab A; Popek EJ; Hui SK; Teruya J; Bandi V; Coburn M; Cunningham T; Martin SR; Belfort MA
    Am J Obstet Gynecol; 2015 Feb; 212(2):218.e1-9. PubMed ID: 25173187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.